|
|||||
|
|
Impact of the variant allele frequency of ASXL1, DNMT3A,JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia |
|
| Authors: | Koji Sasaki MD Rashmi Kanagal-Shamanna MD Guillermo Montalban-Bravo MD Rita Assi MD Elias Jabbour MD Farhad Ravandi MD Tapan Kadia MD Sherry Pierce RN BS BA Koichi Takahashi MD Graciela Nogueras Gonzalez MPH Keyur Patel MD PhD Kelly A. Soltysiak PhD Jorge Cortes MD Hagop M. Kantarjian MD Guillermo Garcia-Manero MD |
| Affiliation: | 1. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas;2. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas;3. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas Division of Hematology-Oncology, Lebanese American University and Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon;4. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| Abstract: | |
| Keywords: | acute myeloid leukemia ASXL1 DNMT3A JAK2 TET2 TP53 |